A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients

HIGHLIGHTS

• who: Youngmin Ko and colleagues from the Department of Surgery, Division of Kidney and Pancreas Transplantation, Asan Medical Center, University have published the article: A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients, in the Journal: PLOS ONE of 12/Oct/2020
• what: Most of the studies were performed in Western countries and only few have focused on determining the optimal dose of ATG in Asian kidney . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.